Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: a competing risk analysis in a national cohort.

van Vugt JLA, Alferink LJM, Buettner S, Gaspersz MP, Bot D, Darwish Murad S, Feshtali S, van Ooijen PMA, Polak WG, Porte RJ, van Hoek B, van den Berg AP, Metselaar HJ, IJzermans JNM.

J Hepatol. 2017 Dec 6. pii: S0168-8278(17)32474-1. doi: 10.1016/j.jhep.2017.11.030. [Epub ahead of print]

PMID:
29221886
2.

Growth of Focal Nodular Hyperplasia is Not a Reason for Surgical Intervention, but Patients Should be Referred to a Tertiary Referral Centre.

Bröker MEE, Klompenhouwer AJ, Gaspersz MP, Alleleyn AME, Dwarkasing RS, Pieters IC, de Man RA, IJzermans JNM.

World J Surg. 2017 Nov 22. doi: 10.1007/s00268-017-4335-6. [Epub ahead of print]

PMID:
29167952
3.

Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.

Broutier L, Mastrogiovanni G, Verstegen MM, Francies HE, Gavarró LM, Bradshaw CR, Allen GE, Arnes-Benito R, Sidorova O, Gaspersz MP, Georgakopoulos N, Koo BK, Dietmann S, Davies SE, Praseedom RK, Lieshout R, IJzermans JNM, Wigmore SJ, Saeb-Parsy K, Garnett MJ, van der Laan LJ, Huch M.

Nat Med. 2017 Dec;23(12):1424-1435. doi: 10.1038/nm.4438. Epub 2017 Nov 13.

PMID:
29131160
4.

Low skeletal muscle mass is associated with increased hospital expenditure in patients undergoing cancer surgery of the alimentary tract.

van Vugt JLA, Buettner S, Levolger S, Coebergh van den Braak RRJ, Suker M, Gaspersz MP, de Bruin RWF, Verhoef C, van Eijck CHC, Bossche N, Groot Koerkamp B, IJzermans JNM.

PLoS One. 2017 Oct 31;12(10):e0186547. doi: 10.1371/journal.pone.0186547. eCollection 2017.

5.

Nonphysician Clinicians in the Follow-Up of Resected Patients with Colorectal Cancer.

Coebergh van den Braak RRJ, Lalmahomed ZS, Büttner S, Hansen BE, Ijzermans JNM; MATCH Study Group.

Dig Dis. 2018;36(1):17-25. doi: 10.1159/000478848. Epub 2017 Sep 29.

PMID:
28965109
6.

Corrigendum to "MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation" [J Hepatol 2013; 59:1231-1238].

Verhoeven CJ, Selten JW, Roest HP, Farid WRR, de Ruiter PE, Hansen BE, de Jonge J, Kwekkeboom J, Metselaar HJ, Tilanus HW, Kazemier G, IJzermans JNM, van der Laan LJW.

J Hepatol. 2017 Sep 27. pii: S0168-8278(17)32279-1. doi: 10.1016/j.jhep.2017.09.001. [Epub ahead of print] No abstract available.

PMID:
28964525
7.

The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma.

van Vugt JLA, Gaspersz MP, Coelen RJS, Vugts J, Labeur TA, de Jonge J, Polak WG, Busch ORC, Besselink MG, IJzermans JNM, Nio CY, van Gulik TM, Willemssen FEJA, Groot Koerkamp B.

HPB (Oxford). 2018 Jan;20(1):83-92. doi: 10.1016/j.hpb.2017.08.025. Epub 2017 Sep 25.

PMID:
28958483
8.

High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.

Coebergh van den Braak RRJ, Sieuwerts AM, Kandimalla R, Lalmahomed ZS, Bril SI, van Galen A, Smid M, Biermann K, van Krieken JHJM, Kloosterman WP, Foekens JA, Goel A, Martens JWM, IJzermans JNM; MATCH study group.

PLoS One. 2017 Sep 28;12(9):e0185607. doi: 10.1371/journal.pone.0185607. eCollection 2017.

9.

Low skeletal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation-a retrospective study.

van Vugt JLA, Buettner S, Alferink LJM, Bossche N, de Bruin RWF, Darwish Murad S, Polak WG, Metselaar HJ, IJzermans JNM.

Transpl Int. 2018 Feb;31(2):165-174. doi: 10.1111/tri.13048. Epub 2017 Sep 21.

PMID:
28871624
10.

Retrospective study on timing of resection of hepatocellular adenoma.

Klompenhouwer AJ, Bröker MEE, Thomeer MGJ, Gaspersz MP, de Man RA, IJzermans JNM.

Br J Surg. 2017 Nov;104(12):1695-1703. doi: 10.1002/bjs.10594. Epub 2017 Aug 30.

PMID:
28857134
11.

Validation of Ultrasonographic Kidney Volume Measurements: A Reliable Imaging Modality.

Janki S, Kimenai HJAN, Dijkshoorn ML, Looman CWN, Dwarkasing JS, IJzermans JNM.

Exp Clin Transplant. 2017 Aug 13. doi: 10.6002/ect.2016.0272. [Epub ahead of print]

12.

Muscle wasting and survival following pre-operative chemoradiotherapy for locally advanced rectal carcinoma.

Levolger S, van Vledder MG, Alberda WJ, Verhoef C, de Bruin RWF, IJzermans JNM, Burger JW.

Clin Nutr. 2017 Jul 13. pii: S0261-5614(17)30240-6. doi: 10.1016/j.clnu.2017.06.028. [Epub ahead of print]

PMID:
28756039
13.

Conditional survival in patients with unresectable perihilar cholangiocarcinoma.

Gaspersz MP, Buettner S, van Vugt JLA, Roos E, Coelen RJS, Vugts J, Belt EJ, de Jonge J, Polak WG, Willemssen FEJA, van Gulik TM, IJzermans JNM, Groot Koerkamp B.

HPB (Oxford). 2017 Nov;19(11):966-971. doi: 10.1016/j.hpb.2017.07.004. Epub 2017 Jul 25.

PMID:
28754366
14.

Contrast-enhancement influences skeletal muscle density, but not skeletal muscle mass, measurements on computed tomography.

van Vugt JLA, Coebergh van den Braak RRJ, Schippers HJW, Veen KM, Levolger S, de Bruin RWF, Koek M, Niessen WJ, IJzermans JNM, Willemsen FEJA.

Clin Nutr. 2017 Jul 14. pii: S0261-5614(17)30246-7. doi: 10.1016/j.clnu.2017.07.007. [Epub ahead of print]

PMID:
28743427
15.

A Model-Based Prediction of the Probability of Hepatocellular Adenoma and Focal Nodular Hyperplasia Based on Characteristics on Contrast-Enhanced Ultrasound.

Taimr P, Bröker MEE, Dwarkasing RS, Hansen BE, de Knegt RJ, De Man RA, IJzermans JNM.

Ultrasound Med Biol. 2017 Oct;43(10):2144-2150. doi: 10.1016/j.ultrasmedbio.2017.05.011. Epub 2017 Jul 22.

PMID:
28743375
16.

Comparison of Postoperative Outcomes Between Donation After Circulatory Death and Donation After Brain Death Liver Transplantation Using the Comprehensive Complication Index.

Kalisvaart M, de Haan JE, Polak WG, Metselaar HJ, Wijnhoven BPL, IJzermans JNM, de Jonge J.

Ann Surg. 2017 Nov;266(5):772-778. doi: 10.1097/SLA.0000000000002419.

PMID:
28742700
17.

Attitudes among transplant professionals regarding shifting paradigms in eligibility criteria for live kidney donation.

Lafranca JA, Spoon EQW, van de Wetering J, IJzermans JNM, Dor FJMF.

PLoS One. 2017 Jul 21;12(7):e0181846. doi: 10.1371/journal.pone.0181846. eCollection 2017.

18.

Long-term outcomes of patients with 10 or more colorectal liver metastases.

Allard MA, Adam R, Giuliante F, Lapointe R, Hubert C, Ijzermans JNM, Mirza DF, Elias D, Laurent C, Gruenberger T, Poston G, Letoublon C, Isoniemi H, Lucidi V, Popescu I, Figueras J.

Br J Cancer. 2017 Aug 22;117(5):604-611. doi: 10.1038/bjc.2017.218. Epub 2017 Jul 20.

PMID:
28728167
19.

Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative.

Coebergh van den Braak RRJ, van Rijssen LB, van Kleef JJ, Vink GR, Berbee M, van Berge Henegouwen MI, Bloemendal HJ, Bruno MJ, Burgmans MC, Busch ORC, Coene PPLO, Coupé VMH, Dekker JWT, van Eijck CHJ, Elferink MAG, Erdkamp FLG, van Grevenstein WMU, de Groot JWB, van Grieken NCT, de Hingh IHJT, Hulshof MCCM, Ijzermans JNM, Kwakkenbos L, Lemmens VEPP, Los M, Meijer GA, Molenaar IQ, Nieuwenhuijzen GAP, de Noo ME, van de Poll-Franse LV, Punt CJA, Rietbroek RC, Roeloffzen WWH, Rozema T, Ruurda JP, van Sandick JW, Schiphorst AHW, Schipper H, Siersema PD, Slingerland M, Sommeijer DW, Spaander MCW, Sprangers MAG, Stockmann HBAC, Strijker M, van Tienhoven G, Timmermans LM, Tjin-A-Ton MLR, van der Velden AMT, Verhaar MJ, Verkooijen HM, Vles WJ, de Vos-Geelen JMPGM, Wilmink JW, Zimmerman DDE, van Oijen MGH, Koopman M, Besselink MGH, van Laarhoven HWM; Dutch Pancreatic Cancer Group, Dutch Upper GI Cancer Group and PLCRC working group.

Acta Oncol. 2018 Feb;57(2):195-202. doi: 10.1080/0284186X.2017.1346381. Epub 2017 Jul 19.

PMID:
28723307
20.

Inflammatory and multiple hepatocellular adenoma are associated with a higher BMI.

Bröker MEE, Gaspersz MP, Klompenhouwer AJ, Hansen BE, Terkivatan T, Taimr P, Dwarkasing R, Thomeer MGJ, de Man RA, IJzermans JNM.

Eur J Gastroenterol Hepatol. 2017 Oct;29(10):1183-1188. doi: 10.1097/MEG.0000000000000930.

PMID:
28704224

Supplemental Content

Loading ...
Support Center